HealthStream (NASDAQ:HSTM) Raised to Strong-Buy at Craig Hallum

HealthStream (NASDAQ:HSTM) was upgraded by analysts at Craig Hallum to a “strong-buy” rating in a note issued to investors on Thursday, Zacks.com reports.

Several other analysts also recently issued reports on the stock. Canaccord Genuity Group lifted their price target on shares of HealthStream from $27.00 to $28.00 and gave the company a “hold” rating in a research report on Wednesday, July 24th. StockNews.com cut HealthStream from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 24th. Two research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, HealthStream currently has an average rating of “Moderate Buy” and a consensus price target of $30.00.

HealthStream Trading Down 0.3 %

NASDAQ HSTM opened at $28.84 on Thursday. HealthStream has a 1 year low of $21.92 and a 1 year high of $31.15. The firm has a market capitalization of $876.68 million, a price-to-earnings ratio of 49.72, a P/E/G ratio of 4.25 and a beta of 0.36. The firm’s 50 day simple moving average is $28.61 and its 200 day simple moving average is $27.79.

HealthStream (NASDAQ:HSTM) last issued its quarterly earnings results on Monday, July 22nd. The technology company reported $0.14 EPS for the quarter, topping analysts’ consensus estimates of $0.12 by $0.02. HealthStream had a net margin of 6.26% and a return on equity of 5.19%. The company had revenue of $71.56 million for the quarter, compared to analyst estimates of $72.85 million. During the same quarter in the previous year, the business earned $0.13 earnings per share. HealthStream’s revenue was up 3.4% compared to the same quarter last year. On average, equities research analysts forecast that HealthStream will post 0.56 earnings per share for the current year.

Insider Activity

In related news, Director Tate Deborah Taylor sold 1,400 shares of HealthStream stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $28.53, for a total transaction of $39,942.00. Following the transaction, the director now directly owns 22,326 shares in the company, valued at approximately $636,960.78. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Tate Deborah Taylor sold 1,400 shares of the firm’s stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $28.53, for a total transaction of $39,942.00. Following the completion of the transaction, the director now directly owns 22,326 shares of the company’s stock, valued at approximately $636,960.78. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Kevin P. O’hara sold 3,000 shares of HealthStream stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total value of $84,090.00. Following the completion of the sale, the senior vice president now directly owns 9,527 shares in the company, valued at approximately $267,041.81. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 20.60% of the company’s stock.

Institutional Investors Weigh In On HealthStream

A number of institutional investors and hedge funds have recently added to or reduced their stakes in HSTM. Quadrature Capital Ltd purchased a new position in HealthStream during the 4th quarter worth $311,000. Diversified Trust Co purchased a new stake in HealthStream during the first quarter worth $213,000. Allspring Global Investments Holdings LLC grew its position in shares of HealthStream by 82.4% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 34,135 shares of the technology company’s stock valued at $910,000 after acquiring an additional 15,425 shares during the period. Wakefield Asset Management LLLP purchased a new stake in shares of HealthStream in the first quarter valued at approximately $909,000. Finally, Sei Investments Co. raised its position in HealthStream by 2.3% during the first quarter. Sei Investments Co. now owns 171,427 shares of the technology company’s stock worth $4,570,000 after acquiring an additional 3,926 shares during the period. Institutional investors own 69.58% of the company’s stock.

About HealthStream

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.